The Prevention And Treatment On Obesity And Weight Management By Oral Supplementation Of Probiotics And Prebiotics

NCT06030999 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-02-21

No results posted yet for this study

Summary

The goal of this interventional study is to test whether consumption of Wonderlab probiotics with prebiotics could improve obesity and overweight in Chinese people who are aged 25-45 and overweight. The main question it aims to answer is:

\- whether the weight of participants can be lost after 10 weeks' intervention

150 participants will be randomized into 3 study groups (50 each group) in the two study sites, who will consume assigned product according to instructions for 10 weeks. Three site visits will be made for each participant and all relevant clinical data will be captured and recorded into CTMS(Clinical Trial Management System) for statistical analysis.

Researchers will compare the three groups to conclude whether the Wonderlab study product can improve obesity and overweight over placebo product.

Conditions

  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Study product A (Wonderlab wonder4shape)

Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks

DIETARY_SUPPLEMENT

Study product B (Wonderlab wonder4shape)

Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks

DIETARY_SUPPLEMENT

Study product C (placebo)

Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks

Sponsors & Collaborators

  • Shenzhen Precision Health Food Technology Co. Ltd.,

    lead OTHER_GOV

Principal Investigators

  • Hongwei Guo, MD · Shanghai Fudan University, School of Public Health

  • Weixing Wang, MD · Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-18
Primary Completion
2023-12-02
Completion
2023-12-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06030999 on ClinicalTrials.gov